The vaccine targets five major serogroups of Neisseria meningitidis (A, B, C, W, and Y) which commonly cause invasive meningococcal disease (IMD).1,2 Tony Wood, Chief Scientific Officer, ...

GSK’s vaccine is the second pentavalent vaccine ... recommended Penbraya for visits where patients are due to get both a Men B and MenACWY vaccine. The committee also unanimously voted to ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya. The shot protects ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

Over half of GSK’s clinical vaccine pipeline has resulted from acquisitions, in-licensing or research and development (R&D) partnerships. GSK offers partners the scale and agility required to ...

GSK’s Arepanrix H5N1 A/American wigeon clade 2.3.4.4b vaccine was designed using recognized technology for seasonal and pandemic flu shots, the PHAC said in a release. Prior to the supply pact ...

GSK, said: "We are excited about the opportunities ahead to help improve meningococcal vaccination coverage in the United States, especially for IMD caused by serogroup B. Building on our global ...

(Reuters) -The U.S. Food and Drug Administration approved British drugmaker GSK's ... vaccine targets the five most common bacterial strains causing the infection - Men A, B, C, W and Y.

Broad serogroup coverage in one vaccine reduces ... Officer, GSK, said: "We are excited about the opportunities ahead to help improve meningococcal vaccination coverage in the United States, ...